-transparent.png){kind=logo}
The five-year survival rate of patients with seminoma (61 cases) of all stages was 81% (seven-year survival rate 67%). Within this group the T1-2N0M0 stage had a five-year survival rate of 100%. Patients with tumours other than seminoma (52 cases) of all stages had a five-year survival rate of 54% (seven-year survival rate 47%). These results and those reported by others are the basis for not advocating routinely total radiation of the lymphatic pathways in the early tumour stages.
Related Publications
E Eibach, and
A C Voss, and
A Junker
January 1977,
Zentralblatt fur Chirurgie,
E Eibach, and
A C Voss, and
A Junker
November 1976,
Anales espanoles de pediatria,
E Eibach, and
A C Voss, and
A Junker
January 1974,
Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology,
E Eibach, and
A C Voss, and
A Junker
October 1978,
Radiobiologia, radiotherapia,
E Eibach, and
A C Voss, and
A Junker
January 1980,
Radiobiologia, radiotherapia,
E Eibach, and
A C Voss, and
A Junker
January 1979,
Acta gastro-enterologica Belgica,
E Eibach, and
A C Voss, and
A Junker
January 1967,
Radiologia clinica et biologica,
E Eibach, and
A C Voss, and
A Junker
January 1982,
Journal d'urologie,
E Eibach, and
A C Voss, and
A Junker
January 1980,
Zentralblatt fur Chirurgie,
E Eibach, and
A C Voss, and
A Junker
May 1975,
MMW, Munchener medizinische Wochenschrift,
